Quantum Leap Healthcare Collaborative™ is a 501C(3) charitable organization integrating high-impact clinical research with patient care to improve and save lives.

PORTFOLIO

Learn more about our projects

I-SPY Trials

Developing new cancer treatments faster and for less

BreastCancerTrials.org

Personalized matching to breast cancer clinical trials

CTMatch

Customizing trial matching to other diseases

OneSource

Radically streamling collection and distribution of data

I-SPY COVID

Focusing on the Problem with an Important New Solution

Visit the I-SPY website for more information.

Latest News

September 2, 2021

Quantum Leap Concludes Famotidine Celebrex Does Not Reduce Recovery Time in the I-SPY COVID Trial

May 18, 2021

ACS CAN & CodeX Lead Project to Expand Cancer Clinical Trial Enrollment Through Improved Technology

April 28, 2021

Quantum Leap Concludes Cenicriviroc Unlikely to Reduce Recovery Time in I-SPY COVID Trial

September 2, 2021

Quantum Leap Concludes Famotidine Celebrex Does Not Reduce Recovery Time in the I-SPY COVID Trial

August 7, 2019

KEYTRUDA’s Success in TNBC Validates I-SPY 2 Adaptive Approach to Phase II Trials

February 15, 2019

Esserman among bioscience leaders profiled in SF Business Times